EXPERIENCE WITH TWO PATIENTS WITH ACTIVATED PI3K DELTA SYNDROME: CASE REPORTS

被引:0
|
作者
Stoner, A.
Kennedy, J.
Berlinski, A.
Jones, S.
Scurlock, A.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P271
引用
收藏
页码:S69 / S69
页数:1
相关论文
共 50 条
  • [41] Characterizing A Novel Variant in ABCB1 in a Family with Activated PI3K Delta Syndrome-like Presentation
    Yilmaz, Melis
    Ujhazi, Boglarka
    Sotoudeh, Shannon
    Patel, Priya
    Nguyen, Minh
    Csomos, Krisztian
    Wang, Ji-Yang
    Farmer, Jocelyn
    Lucas, Carrie
    Walter, Jolan
    CLINICAL IMMUNOLOGY, 2023, 250 : 135 - 135
  • [42] Case Report: Early-onset or recalcitrant cytopenias as presenting manifestations of activated PI3Kδ syndrome
    Remiker, Allison S.
    Lopes, Joao Pedro Matias
    Jesudas, Rohith
    Superdock, Alexandra
    Park, Nami
    Pateva, Irina
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [43] The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS)
    Fekrvand, Saba
    Delavari, Samaneh
    Chavoshzadeh, Zahra
    Sherkat, Roya
    Mahdaviani, Seyed Alireza
    Shabestari, Mahnaz Sadeghi
    Azizi, Gholamreza
    Arzanian, Mohammad Taghi
    Shamsian, Bibi Shahin
    Eskandarzadeh, Shabnam
    Eslami, Narges
    Rae, William
    Condino-Neto, Antonio
    Mohammadi, Javad
    Abolhassani, Hassan
    Yazdani, Reza
    Aghamohammadi, Asghar
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (03) : 644 - 659
  • [44] Phenotypic characterization of patients with activated PI3Kδ syndrome 1 presenting with features of systemic lupus erythematosus
    Wang, Yanping
    Yang, Qiuyun
    Chen, Xuemei
    Tang, Wenjing
    Zhou, Lina
    Chen, Zhi
    An, Yunfei
    Zhang, Zhiyong
    Tang, Xuemei
    Zhao, Xiaodong
    GENES & DISEASES, 2021, 8 (06) : 907 - 917
  • [45] ACTIVATED PHOSPHOINOSITIDE 3-KINASE (PI3K) DELTA SYNDROME (APDS) MAY HIDE BEHIND EVOLVING MANIFESTATIONS IN EARLY CHILDHOOD
    Kubala, S.
    Uzel, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S103 - S103
  • [46] International Retrospective Study of Allogeneic Hematopoietic Cell Transplantation (HCT) for Activated Phosphoinositide 3-Kinase Delta (PI3K) Syndrome
    Dimitrova, Dimana
    Nademi, Zohreh
    Maccari, Maria Elena
    Ehl, Stephan
    Lankester, Arjan C.
    Gennery, Andrew
    Uzel, Gulbu
    Laberko, Alexandra
    Mukhina, Anna
    Ip, Winnie
    Rao, Kanchan
    Worth, Austen J. J.
    Speckmann, Carsten
    Wehr, Claudia
    Abolhassani, Hassan
    Aghamohammadi, Asghar
    Bleesing, Jack J.
    Dara, Jasmeen
    Dvorak, Christopher C.
    Ghosh, Sujal
    Kang, Hyoung Fin
    Markelj, Gasper
    Modi, Arunkumar
    Bayer, Diana
    Notarangelo, Luigi D.
    Schulz, Ansgar
    Garcia-Prat, Marina
    Soler-Palacin, Pere
    Kurakukcu, Musa
    Yilmaz, Ebru
    Slatter, Mary
    Kanakry, Jennifer A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S14 - S15
  • [47] The Role of PI3kγ and PI3kΔ in Alloimmunity
    Uehara, M.
    Jamil, A.
    Solhjou, Z.
    McGrath, M.
    Banouni, N.
    Evans, C.
    Dinitto, J.
    Winkler, D.
    Abdi, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 325 - 325
  • [48] The role of PI3kγ and PI3kδ in alloimmunity
    Uehara, Mayuko
    Jamil, Azzi
    Ohori, Shunsuke
    Solhjou, Zhabiz
    McGrath, Martina
    Banouni, Naima M.
    Evans, Catherine A.
    Dinitto, Jonathan P.
    Winkler, David G.
    Abdi, Reza
    TRANSPLANTATION, 2016, 100 (07) : S361 - S361
  • [49] PI3K targeted inhibition in NSCLC: An in vitro evaluation and correlation of mutation status to activated PI3K pathway signaling in NSCLC patients
    Heavey, Susan
    Toomey, Sinead
    Carr, Aoife
    Cuffe, Sinead
    Finn, Stephen
    Hennessy, Bryan
    Crown, John
    Barr, Martin
    O'Byrne, Kenneth
    Gately, Kathy
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [50] Bringing PI3K Delta Inhibitors to Cancer Treatment
    不详
    CANCER DISCOVERY, 2011, 1 (01) : OF4 - OF4